Compare BGC & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGC | RDNT |
|---|---|---|
| Founded | 1945 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.6B |
| IPO Year | 1999 | 1996 |
| Metric | BGC | RDNT |
|---|---|---|
| Price | $10.79 | $65.59 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $82.80 |
| AVG Volume (30 Days) | ★ 3.7M | 948.2K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | ★ 24.00 | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $2,941,460,000.00 | $1,616,630,000.00 |
| Revenue This Year | $22.26 | $22.78 |
| Revenue Next Year | $7.03 | $10.70 |
| P/E Ratio | $64.53 | ★ N/A |
| Revenue Growth | ★ 29.99 | 13.05 |
| 52 Week Low | $8.27 | $50.79 |
| 52 Week High | $12.89 | $85.84 |
| Indicator | BGC | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 44.92 | 61.86 |
| Support Level | $10.26 | $64.71 |
| Resistance Level | $11.73 | $74.55 |
| Average True Range (ATR) | 0.51 | 2.71 |
| MACD | -0.10 | 0.58 |
| Stochastic Oscillator | 21.05 | 70.57 |
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, the Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.